Literature DB >> 23428707

High glucose variability increases cerebral infarction in patients with spontaneous subarachnoid hemorrhage.

Jeffrey F Barletta1, Bryan E Figueroa, Rob DeShane, Steven A Blau, Karen J McAllen.   

Abstract

PURPOSE: High glucose variability is a significant marker for poor outcome in critically ill patients. We evaluated the impact of high glucose variability on cerebral infarction following spontaneous subarachnoid hemorrhage (SAH).
MATERIALS AND METHODS: Consecutive adult patients with spontaneous SAH and Hunt Hess score of at least 3 were retrospectively identified. Patients were excluded if their intensive care unit length of stay was less than 24 hours or if there were less than 5 glucose assessments. Glucose values from the first 7 days of intensive care unit admission were assessed. Variability was calculated as the average change in glucose over time for each patient. Classification and regression tree analysis was used to determine high vs low glucose variability, and the incidence of cerebral infarction was compared. Multivariate analysis was used to control for confounding variables.
RESULTS: There were 42 patients. Classification and regression tree analysis revealed a change in glucose greater than 9.52 mg/dL/h as the determinant for high variability. The incidence of cerebral infarction was 64% when glucose variability was high vs 20% when it was low (P=.006). Multivariate analysis identified high glucose variability (odds ratio [95% confidence interval]=11.4 [1.9-70.2], P=.008) and female sex (odds ratio [95% confidence interval]=5.2 [1-26.8], P=.047) as independent predictors for cerebral infarction.
CONCLUSION: Glucose variability is a significant predictor of cerebral infarction in patients with severe spontaneous SAH.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucose; Infarction; Subarachnoid hemorrhage; Variability

Mesh:

Substances:

Year:  2013        PMID: 23428707     DOI: 10.1016/j.jcrc.2012.12.012

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  4 in total

Review 1.  Clinical relevance of glucose metrics during the early brain injury period after aneurysmal subarachnoid hemorrhage: An opportunity for continuous glucose monitoring.

Authors:  Daniel Santana; Alejandra Mosteiro; Leire Pedrosa; Laura Llull; Ramón Torné; Sergi Amaro
Journal:  Front Neurol       Date:  2022-09-12       Impact factor: 4.086

2.  Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study.

Authors:  Pedro Kurtz; Jan Claassen; Raimund Helbok; J Schmidt; Luis Fernandez; Mary Presciutti; R Morgan Stuart; E Sander Connolly; Kiwon Lee; Neeraj Badjatia; Stephan A Mayer
Journal:  Crit Care       Date:  2014-05-04       Impact factor: 9.097

Review 3.  Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome.

Authors:  Tomoya Okazaki; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2018-05-08

4.  Clinical Implications of Serial Glucose Measurements in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.

Authors:  Joon-Tae Kim; Se-Young Lee; Deok-Sang Yoo; Ji Sung Lee; Sang-Hoon Kim; Kang-Ho Choi; Man-Seok Park; Ki-Hyun Cho
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.